Candida albicans endophthalmitis after extracorporeal shock wave lithotripsy in a patient with liver cirrhosis

Internal Medicine

Volumn 45, Issue 22, 2006, Pages 1327-1332

  Toshikuni, Nobuyuki ^a   Ujike, Kazuhiro ^a   Yanagawa, Toshihiro ^a   Suga, Tatsuhito ^a   Shimizu, Toshinari ^a   Kusuda, Yuji ^a   Okamoto, Masayuki ^a   Ogawa, Takayoshi ^a   Yuasa, Shiro ^a  

^a HIMEJI RED CROSS HOSPITAL   (Japan)

Author keywords

Candida albicans; Endophthalmitis; Extracorporeal shock wave lithotripsy; Fungemia; Liver cirrhosis

Indexed keywords

ALBUMIN; CEFPIRAMIDE; CILASTATIN PLUS IMIPENEM; DIURETIC AGENT; DOPAMINE; FLUCONAZOLE; MICAFUNGIN;

AGED; ARTICLE; ASCITES; CANDIDIASIS; CASE REPORT; DRUG DOSE INCREASE; ENDOPHTHALMITIS; EXTRACORPOREAL LITHOTRIPSY; FUNGEMIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER FAILURE; LOW DRUG DOSE; MALE; PATIENT REFERRAL; RELAPSE; URETER STONE; URINARY TRACT INFECTION; VITRECTOMY;

AGED; CANDIDIASIS; ENDOPHTHALMITIS; HUMANS; KIDNEY FAILURE; LITHOTRIPSY; LIVER CIRRHOSIS; LIVER FAILURE; MALE; OPHTHALMOSCOPY; RECURRENCE; URETERAL CALCULI;

EID: 33845636639     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1761     Document Type: Article

References (25)

1. Akler ME, Vellend H, McNeely DM, Watmsley SL, Gold WL. Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis 20: 657-664, 1995.
2. Roth RA, Beckmann CF. Complications of extracorporeal shock-wave lithotripsy and percutaneous nephrolithotomy. Urol Clin North Am 15: 155-166, 1988.
3. Heilesen AM, Krogh E. Candida albicans endophthalmitis following extra-corporeal shock wave lithotripsy of a kidney stone. Acta Ophthalmol (Copenh) 67: 478, 1989.
4. Westh H, Mogensen P. Extracorporeal shock wave lithotripsy of a kidney stone complicated with Candida albicans septicaemia and endophthalmitis. Case report. Scand J Urol Nephrol 24: 81, 1990.
5. Greenwald BD, Tunkel AR, Morgan KM, Campochiaro PA, Donowitz GR. Candidal endophthalmitis after lithotripsy of renal calculi. South Med J 85: 773-774, 1992.
6. Cochran JS, Robinson SN, Crane VS, Jones DG. Extracorporeal shock wave lithotripsy. Use of antibiotics to avoid postprocedural infection. Postgrad Med 83: 199-204, 1988.
7. Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 32: 1602-1607, 2001.
8. Deliveliotis C, Giftopoulos A, Koutsokalis G, Raptidis G, Kostakopoulos A. The necessity of prophylactic antibiotics during extracorporeal shock wave lithotripsy. Int Urol Nephrol 29: 517-521, 1997.
9. Yeniyol CO, Tuna A, Yener H, Zeyrek N, Tilki A, Coskuner A. Bacterial colonization of double J stents and bacteriuria. frequency. Int Urol Nephrol 34: 199-202, 2002.
10. Maid DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7: 342-347, 2001.
11. Wong F, Bernardi M, Balk R, et al. International Ascites Club. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54: 718-725, 2005.
12. Iber FL. Patients with cirrhosis and liver failure are at risk for bacterial and fungus infection. Am J Gastroenterol 94: 2001-2003, 1999.
13. Hassner A, Kletter Y, Shlag D, Yedvab M, Aronson M, Shibolet S. Impaired monocyte function in liver cirrhosis. Br Med J (Clin Res Ed) 282: 1262-1263, 1981.
14. Garcia-Gonzalez M, Boixeda D, Herrero D, Burgaleta C. Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis. Gastroenterology 105: 527-531, 1993.
15. Cha R, Sobel JD. Fluconazole for the treatment of candidiasis: 15 years experience. Expert Rev Anti Infect Ther 2: 357-366, 2004.
16. Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 129: 1944-1953, 2005.
17. Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 149: 2226-2228, 1989.
18. Menezes AV, Sigesmund DA, Demajo WA, Devenyi RG. Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med 154: 2093-2097, 1994.
19. Krishna R, Amuh D, Lowder CY, Gordon SM, Adal KA, Hall G. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye 14: 30-34, 2000.
20. Wildfeuer A, Laufen H, Schmalreck AF, Yeates RA, Zimmermann T. Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility. Mycoses 40: 259-265, 1997.
21. Tawara S, Ikeda F, Maki K, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 44: 57-62, 2000.
22. Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S. National surveillance of species distribution in blood isolates of Candida, species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53: 283-289, 2004.
23. Mochizuki K, Murase H, Otani S, et al. Three cases of endogenous endophthalmitis treated with micafungin. Progress in Medicine 24: 2807-2811, 2004 (in Japanese).
24. Hidalgo JA, Alangaden GJ, Eliott D, et al. Fungal endophthalmitis diagnosis by detection of Candida albicans DNA in intraocular fluid by use of a species-specific polymerase chain reaction assay. J Infect Dis 181: 1198-1201, 2000.
25. Aanestad O, Eilard T. Severe candida cystitis with perforation of the urinary bladder. Scand J Urol Nephrol 31: 311-312, 1997.